SZ

Syeda Zahra Farees

Active Director Director DIN 09856625
DIN 09856625 First appointment Jan 2023 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Syeda Zahra Farees

Data last updated:

Syeda Zahra Farees is a Director at American Super Speciality Hospitals Private Limited (since 2023). The company operates in Non-Profit Organizations.

DIN 09856625
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 10 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jan 20232023Active

Board colleagues of Syeda Zahra Farees

Directorship timeline

Open interactive timeline →
American Super Speciality Hospitals Private Limited
Premium access

Shareholding and investment profile for Syeda Zahra Farees

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syeda Zahra Farees

Syeda Zahra Farees currently holds 1 directorship: American Super Speciality Hospitals Private Limited (Director, since 10 Jan 2023).

Syeda Zahra Farees was first appointed on 10 Jan 2023 as Director at American Super Speciality Hospitals Private Limited.

The current boards of Syeda Zahra Farees's companies include Syed Nusrath Farees (American Super Speciality Hospitals Private Limited), Syeda Hajera Farees (American Super Speciality Hospitals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available